Zealand Pharma A/S (22Z.SG)
| Previous close | 120.80 |
| Open | 119.00 |
| Bid | 121.90 x 200000 |
| Ask | 123.20 x 388000 |
| Day's range | 119.00 - 123.20 |
| 52-week range | 37.32 - 130.30 |
| Volume | |
| Avg. volume | 102 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Bloomberg
Denmark’s Top Pension Fund Buys Weight-Loss Stocks After Run-Up
(Bloomberg) -- ATP, Denmark’s biggest pension fund with about $100 billion in assets, is doubling down on its investment in Danish obesity companies, increasing the country’s reliance on weight-loss stocks after a recent run-up. Most Read from BloombergTurkey Plans Istanbul Taxi Surge to Tackle ComplaintsIntergenerational Housing Could Help Older Adults Combat LonelinessAs Rural Hospitals Shutter Maternity Wards, Urban Ones FollowNazi Bunker’s Leafy Makeover Turns Ugly Past Into Urban Eyecatcher
- Investing.com
Zealand Pharma rebound after prior session losses
Shares in Zealand Pharma (CSE:ZELA) rose on Tuesday, recovering losses from the previous session which came in the wake of comments by the company's CEO about seeking a large pharmaceutical partner for the company’s weight loss drug. At 5:02 am (0902 GMT), Zealand Pharma was trading 3.8% higher at DKK 943.50. Analysts at Jefferies have highlighted the company’s promising amylin pipeline and potential for lucrative partnerships as key drivers for the share price increase.
- Zacks
Here's What Could Help Zealand Pharma AS (ZLDPF) Maintain Its Recent Price Strength
If you are looking for stocks that are well positioned to maintain their recent uptrend, Zealand Pharma AS (ZLDPF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
